Inclusion Criteria:~* Diagnoses of Alzheimer's disease according to the National Institute of Neurological and
Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA)
criteria.~* Presence of a caregiver (friend or relative) who can assume responsibility for medication
administrations, accompany the patient to all visits, and rate patient's condition.~* Written informed consent
form from both the patient (or surrogate) and caregiver.~* A Mini-Mental State Examination score between 12 and
26 inclusive.~* Prescription of donepezil (5-10mg/d), rivastigmine (3-6mg/d), galantamine or galantamine ER
(8-16mg/d) for a minimum of 4 weeks prior to randomization.~* Agreement not to take hydralazine.~* Age 49 and
over.~
